R3 Vascular raises $17.8m for devices to treat peripheral artery diseases
October 10, 2020 No Comment
R3 Vascular, an early-stage US medical device company, has raised $17.8 million in a Series A financing round, led by an undisclosed corporate investor and 415 CAPITAL. The funding comprised new equity investments of $15 million and the conversion of $2.8 million of convertible notes. The Series A round also saw participation from HBM-MedFocus and Wexford […]
Continue reading …
Apellis Pharmaceuticals has reported positive results for pegcetacoplan from the phase 2 DISCOVERY clinical trial in patients with C3 glomerulopathy (C3G), a type of kidney disease. According to the US biopharma company, the 48-week results demonstrated that patients subjected to pegcetacoplan had sustained improvements across key clinical measures. These include a greater than 65% mean […]
Continue reading …
Bristol Myers Squibb (BMS) has agreed to acquire California-based clinical-stage biopharma company MyoKardia for $13.1 billion, to gain access to the latter’s cardiovascular drug candidate mavacamten. The US pharma giant is offering to acquire MyoKardia for $225.00 per share in an all-cash deal. Mavacamten is being developed for the treatment of a chronic heart disease […]
Continue reading …
AstraZeneca has been granted breakthrough therapy designation (BTD) for Farxiga (dapagliflozin) from the US Food and Drug Administration (FDA) for the treatment of patients with chronic kidney disease (CKD), irrespective of type 2 diabetes (T2D). According to the US Centers for Disease Control and Prevention (CDC), chronic kidney disease is a serious, progressive condition defined […]
Continue reading …Dr. Reddy’s launches Sapropterin Dihydrochloride Tablets generic version in US
October 4, 2020 No Comment
Indian pharma company Dr. Reddy’s Laboratories has launched a generic version of phenylalanine hydroxylase activator Sapropterin Dihydrochloride Tablets, for oral use, in the US market. Sapropterin Dihydrochloride Tablets are indicated in the US for reducing blood phenylalanine (Phe) levels in adult and pediatric patients, aged one month and older with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- […]
Continue reading …
Covis Group, a Luxembourg specialty pharma company, has agreed to acquire US biopharma company AMAG Pharmaceuticals for about $647 million, which includes the latter’s debt. As per the terms of the deal, Covis Group will acquire AMAG Pharmaceuticals for $13.75 per share in cash, or nearly $498 million. Covis Group is making the acquisition to […]
Continue reading …
OliX Pharmaceuticals, a South Korean pharma company, has submitted an investigational new drug (IND) application to the US Food and Drug Administration (FDA) seeking its consent to begin a phase 2a clinical trial for OLX10010 in reducing the recurrence of hypertrophic scars after scar revision surgery. The developer of RNAi therapeutics intends to assess the […]
Continue reading …
Millendo Therapeutics has started a phase 1 clinical trial of its selective neurokinin 3 receptor (NK3R) antagonist MLE-301, which is being developed for the treatment of menopausal women with vasomotor symptoms (VMS). VMS is known commonly as hot flashes and night sweats in menopausal women. The Michigan-based biopharma company has dosed the first subject in […]
Continue reading …
ENSEMBLE Covid-19 vaccine trial : Johnson & Johnson (J&J) has launched a multi-nation phase 3 trial called ENSEMBLE for its JNJ-78436735 Covid-19 vaccine candidate (Ad26.COV2.S), which is being developed by its subsidiary – Janssen Pharmaceutical Companies. The US healthcare giant said that the ENSEMBLE vaccine trial has been initiated following positive interim results from its […]
Continue reading …Ampersand acquires majority stake in in vitro diagnostics company ALPCO
September 21, 2020 No Comment
Ampersand Capital Partners, a middle-market private equity firm, has acquired a majority stake in American Laboratory Products Company (ALPCO), an in vitro diagnostics company, for an undisclosed price. Established in 1990, ALPCO started off as an importer and distributor of immunoassay-based products serving the North American life science markets. Currently, the company offers its proprietary […]
Continue reading …
Business News Today
- Chinese lifestyle product retailer MINISO opens new store in Madrid
- Unilever to acquire Los Angeles-based SmartyPants Vitamins
- Bega Cheese to acquire Lion Dairy & Drinks for $412m
- Nestlé to sell Yinlu peanut milk and canned rice porridge businesses in China
- TEXRail extension project : Trinity Metro selects AECOM as project consultant
- Castle Mountain Gold Mine California : Equinox Gold achieves commercial production
- McCormick to acquire Mexican hot sauce brand Cholula Hot Sauce
- Elliott Advisors offers to take over Swiss food company Aryzta for CHF0.8 per share
- US challenger bank Current raises $131m in Series C round
- HelloFresh to acquire US meal delivery service provider Factor75
